Innovation Pharmaceuticals Inc (IPIX)

[williamssc]

Polymedix bk had zero to do with B. Those multiple hit pieces had everything to do with ctix share price tanking.

A doomed Covid-19 trial on deaths door patients is what killed the stock last November but now further testing lately shows B proving out as a broad spectrum anti-viral. IPIX payer analysis shows B would be well received as a OM treatment. Why was a payer analysis done? Surely the need clear up disagreements today as the worth of B-OM when it goes to market. Otherwise why?Time will tell.

We have a lot a lot of good anti-viral data out of covid. No guarantees but we are still in the running here. I believe IPIX is undervalued and it's not all doom and gloom.